BRCA1 and neoplasm: We consider this explanation unlikely for two reasons: (i) mammalian cells that tolerate BRCA1 deficiency because of additional tumour promoting mutants are reliant for their survival on TMEJ; under these conditions TMEJ activity is thus sufficient, (ii) C. elegans brc-1 mutants survive TMEJ impairment.